168 related articles for article (PubMed ID: 38448965)
21. Blockade of CCR7 leads to decreased dendritic cell migration to draining lymph nodes and promotes graft survival in low-risk corneal transplantation.
Hos D; Dörrie J; Schaft N; Bock F; Notara M; Kruse FE; Krautwald S; Cursiefen C; Bachmann BO
Exp Eye Res; 2016 May; 146():1-6. PubMed ID: 26689751
[TBL] [Abstract][Full Text] [Related]
22. Safety and Efficacy of OXB-202, a Genetically Engineered Tissue Therapy for the Prevention of Rejection in High-Risk Corneal Transplant Patients.
Fouladi N; Parker M; Kennedy V; Binley K; McCloskey L; Loader J; Kelleher M; Mitrophanous KA; Stout JT; Ellis S
Hum Gene Ther; 2018 Jun; 29(6):687-698. PubMed ID: 29361840
[TBL] [Abstract][Full Text] [Related]
23. Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases.
Bock F; Maruyama K; Regenfuss B; Hos D; Steven P; Heindl LM; Cursiefen C
Prog Retin Eye Res; 2013 May; 34():89-124. PubMed ID: 23348581
[TBL] [Abstract][Full Text] [Related]
24. Corneal collagen cross-linking for treating keratoconus.
Sykakis E; Karim R; Evans JR; Bunce C; Amissah-Arthur KN; Patwary S; McDonnell PJ; Hamada S
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010621. PubMed ID: 25803325
[TBL] [Abstract][Full Text] [Related]
25. The effect of donor age on corneal transplantation outcome results of the cornea donor study.
; gal RL; Dontchev M; Beck RW; Mannis MJ; Holland EJ; Kollman C; Dunn SP; Heck EL; Lass JH; Montoya MM; Schultze RL; Stulting RD; Sugar A; Sugar J; Tennant B; Verdier DD
Ophthalmology; 2008 Apr; 115(4):620-626.e6. PubMed ID: 18387407
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological correlation analysis of (lymph) angiogenesis and corneal graft rejection.
Zheng Y; Lin H; Ling S
Mol Vis; 2011; 17():1694-700. PubMed ID: 21738399
[TBL] [Abstract][Full Text] [Related]
27. Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty.
Abudou M; Wu T; Evans JR; Chen X
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007603. PubMed ID: 26313245
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic Therapy Leads to Time-Dependent Regression of Pathologic Corneal (Lymph) Angiogenesis and Promotes High-Risk Corneal Allograft Survival.
Hou Y; Le VNH; Clahsen T; Schneider AC; Bock F; Cursiefen C
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5862-5869. PubMed ID: 29145577
[TBL] [Abstract][Full Text] [Related]
29. Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial.
Eskandary F; Dürr M; Budde K; Doberer K; Reindl-Schwaighofer R; Waiser J; Wahrmann M; Regele H; Spittler A; Lachmann N; Firbas C; Mühlbacher J; Bond G; Halloran PF; Chong E; Jilma B; Böhmig GA
Trials; 2019 Jan; 20(1):37. PubMed ID: 30635033
[TBL] [Abstract][Full Text] [Related]
30. Effect of Corneal Cross-linking versus Standard Care on Keratoconus Progression in Young Patients: The KERALINK Randomized Controlled Trial.
Larkin DFP; Chowdhury K; Burr JM; Raynor M; Edwards M; Tuft SJ; Bunce C; Caverly E; Doré C;
Ophthalmology; 2021 Nov; 128(11):1516-1526. PubMed ID: 33892046
[TBL] [Abstract][Full Text] [Related]
31. Clinical transplantation of individualized recipient serum-adapted cornea reduces the risk of graft rejection after keratoplasty.
Thanos S; Gatzioufas Z; Schallenberg M; König S; Meyer-Rüsenberg HW; Busse H
Cell Transplant; 2013; 22(3):477-91. PubMed ID: 23043892
[TBL] [Abstract][Full Text] [Related]
32. Lymphatic vessels in the development of tissue and organ rejection.
Hos D; Cursiefen C
Adv Anat Embryol Cell Biol; 2014; 214():119-41. PubMed ID: 24276891
[TBL] [Abstract][Full Text] [Related]
33. Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation.
Dietrich T; Bock F; Yuen D; Hos D; Bachmann BO; Zahn G; Wiegand S; Chen L; Cursiefen C
J Immunol; 2010 Jan; 184(2):535-9. PubMed ID: 20018627
[TBL] [Abstract][Full Text] [Related]
34. A study protocol for a multicentre randomised clinical trial evaluating the safety and feasibility of a bioengineered human allogeneic nanostructured anterior cornea in patients with advanced corneal trophic ulcers refractory to conventional treatment.
González-Andrades M; Mata R; González-Gallardo MDC; Medialdea S; Arias-Santiago S; Martínez-Atienza J; Ruiz-García A; Pérez-Fajardo L; Lizana-Moreno A; Garzón I; Campos A; Alaminos M; Carmona G; Cuende N
BMJ Open; 2017 Sep; 7(9):e016487. PubMed ID: 28947445
[TBL] [Abstract][Full Text] [Related]
35. VEGF-trap aflibercept significantly improves long-term graft survival in high-risk corneal transplantation.
Dohlman TH; Omoto M; Hua J; Stevenson W; Lee SM; Chauhan SK; Dana R
Transplantation; 2015 Apr; 99(4):678-86. PubMed ID: 25606789
[TBL] [Abstract][Full Text] [Related]
36. Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial.
Orban JC; Fontaine E; Cassuto E; Baumstarck K; Leone M; Constantin JM; Ichai C;
Trials; 2018 Apr; 19(1):231. PubMed ID: 29665840
[TBL] [Abstract][Full Text] [Related]
37. Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs.
Koenig Y; Bock F; Kruse FE; Stock K; Cursiefen C
Cornea; 2012 Aug; 31(8):887-92. PubMed ID: 22362005
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with corneal graft survival in the cornea donor study.
; Sugar A; Gal RL; Kollman C; Raghinaru D; Dontchev M; Croasdale CR; Feder RS; Holland EJ; Lass JH; Macy JI; Mannis MJ; Smith PW; Soukiasian SH; Beck RW
JAMA Ophthalmol; 2015 Mar; 133(3):246-54. PubMed ID: 25322173
[TBL] [Abstract][Full Text] [Related]
39. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants.
Qian Y; Boisgerault F; Benichou G; Dana MR
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):987-94. PubMed ID: 11274076
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
